Marker Therapeutics (MRKR) had the highest return in 2000 by a US stock in the Nasdaq Composite (IXIC), returning 4,877,948.8%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Marker Therapeutics (MRKR) | 2000 | 4,877,948.78% |
Inseego (INSG) | 2000 | 3,093,650% |
CervoMed (CRVO) | 2000 | 95,138.06% |
Alpha Compute (ALP) | 2000 | 58,013.21% |
Alto Ingredients (ALTO) | 2000 | 7,548.6% |
Live Ventures (LIVE) | 2000 | 4,365.63% |
Insmed (INSM) | 2000 | 1,069.58% |
Sanara Medtech (SMTI) | 2000 | 650% |
FuelCell Energy (FCEL) | 2000 | 452.64% |
Manhattan Associates (MANH) | 2000 | 452.23% |
374Water Inc Common Stock (SCWO) | 2000 | 400% |
CVD Equipment (CVV) | 2000 | 342.86% |
Vertex Pharmaceuticals (VRTX) | 2000 | 302.82% |
RadNet (RDNT) | 2000 | 264.71% |
Myriad Genetics (MYGN) | 2000 | 258.32% |
XOMA Royalty (XOMA) | 2000 | 221.65% |
Hallador Energy (HNRG) | 2000 | 214.33% |
Abeona Therapeutics (ABEO) | 2000 | 211.65% |
Patterson-UTI Energy (PTEN) | 2000 | 187.92% |
SEI Investments (SEIC) | 2000 | 179.24% |
Cerus (CERS) | 2000 | 178.7% |
Innodata (INOD) | 2000 | 177.16% |
Celldex Therapeutics (CLDX) | 2000 | 175% |
G Willi-Food International (WILC) | 2000 | 171.98% |
Regeneron Pharmaceuticals (REGN) | 2000 | 167.42% |